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INTRODUCTION 
Investigations of the processes by which organisms synthesize or 
degrade cellular components have produced metabolic maps that depict the 
series of enzymatic steps involved in the reactions. While all the 
reactions which are necessary to permit growth and maintenance of cells 
are by no means known, it is very evident that these processes require 
a highly integrated, enzyme-mediated Interplay of anabollsm and 
catabolism. 
Some of these metabolic processes concern the synthesis of amino 
acids, which are the basic units of enzymes and other proteinaceous cellu­
lar components. Since the mechanisms of metabolism depend upon enzymes as 
the functional factors, the regulation of the synthesis and activity of 
enzymes is of primary Importance to the cell. 
The higher plants and animals are multicellular organisms consisting 
of many differentiated, specialized and interacting cells. The complexity 
of these organisms renders it difficult to recognize the mechanisms that 
regulate cellular functions. The use of microorganisms, however, has the 
advantages of a greatly decreased level of interaction between cells, rapid 
growth, and yet a broad range of nutritional requirements. 
This study is concerned with the biosynthesis of isoleuclne and valine 
in Staphylococcus aureus. This organism was chosen not only because it is 
a pathogen of man and therefore of clinical importance, but also because 
previous studies of its biosynthetic properties have been mainly concerned 
with these functions involved with pathogenicity or with biochemical 
genetics. It is hoped that studies of the type reported here on aureus 
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will aid in understanding the relationships of this organism to other 
organisms, and in understanding cellular functions and their regulation. 
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LITERATURE REVIEW 
Our knowledge of amino acid biosynthesis has been accumulated in 
several overlapping phases. The initial phase concerned the isolation and 
identification of amino acids in protein hydrolysates. This led to nutri­
tional studies to determine which amino acids are required by mono- and 
multi-cellular organisms, providing the basis for the concept that certain 
amino acids could be synthesized by a particular organism while others 
could not. Since isotopes could be easily traced and isolated, their 
application to biological studies provided a convenient means of deter­
mining biosynthetic sequences. And since microorganisms displayed great 
variations in nutritional requirements, they were a logical selection for 
use in investigations of the biosynthesis of amino acids. 
One of the results of these investigations has been the development 
of metabolic maps depicting the series of reactions by which amino acids 
(and other cellular components) are formed. Such a sequence for the bio­
synthesis of isoleucine and valine, as considered to exist in microorgan­
isms, is presented in Fig. 1. As illustrated, the over-all biosynthetic 
pathway involves, except for the first step in isoleucine biosynthesis, 
reactions that are catalyzed by bifunctional enzymes, i.e., each enzyme 
that catalyzes a step in the valine pathway catalyzes the corresponding 
step in the isoleucine pathway. In addition, an intermediate, alpha-
ketoisovalerate (KV) in the valine pathway is involved in the biosynthesis 
of leucine and pantothenate. 
Studies on this biosynthetic sequence were considerably advanced when 
Beadle and Tatum (1941) Introduced the use of auxotrophic mutants of 
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Fig. 1. Pathway of biosynthesis of isoleucine and valine (De Robichon-Szulmajster and Magee, 
1968; Allaudeen and Ramakrishnan, 1968). Enzyme 1 = threonine deaminase; enzyme 2 = 
acetohydroxy acid synthetase; enzyme 3 = reductoiosmerase; enzyme 4 = dihydroxy acid 
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Neurospora crassa. One of these mutants, strain 16117, was found to 
require both isoleucine and valine. Subsequent studies by Bonner, Tatum 
and Beadle (1943) demonstrated that mutant 16117 could utilize alpha-
ketoisovalerate (KV*) and alpha-keto-beta-methylvalerate (KI) in place of 
isoleucine and valine. However, when Bonner (1946) attempted to repeat 
the growth experiments with chemically synthesized keto acids, he found 
that the mutant could utilize synthetic KV in a medium supplemented with 
isoleucine, but could not utilize the synthetic KI in a medium containing 
valine. He therefore proposed that the genetic block in the isoleucine 
pathway resulted in an accumulation of an intermediate which then inter-
ferred with the valine biosynthetic pathway. 
These early studies were supplemented by results obtained with mutant 
and wild-type strains of Escherichia coli. Tatum (1946) found that the 
growth of coli strain K-12 was inhibited by valine, and that the inhi­
bition could b reversed by isoleucine. In addition, certain mutants of 
strain K-12 required only isoleucine for growth. However, Teas (1948) 
observed that these mutants could also utilize alpha-ketobutyrate (KB) or 
synthetically prepared KI (Bonner, 1946). 
Since the wild-type strains of coli and IJ. crassa could grow in 
media lacking isoleucine and valine, the isolation of mutants requiring 
either one or both of the amino acids suggested that the isolates were 
genetically blocked at some step in the formation of these amino acids. 
*The chemical names given to the Intermediates in the isoleucine-
valine biosynthetic pathway are not the same in all publications. There­
fore, to avoid confusion, the chemical names accepted at present have 
been substituted for any different names given in the references. 
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Therefore, mutants were grown in media containing limiting amounts of iso-
leucine and valine to determine whether compounds that might be inter­
mediates in the biosynthesis of isoleucine and valine would accumulate in 
the media. These procedures were used to isolate and identify KV and KI 
(the immediate precursors of isoleucine and valine) from culture filtrates 
of a mutant of strain K-12 of coli (Umbarger and Magasanik, 1951). 
Similar methods were used to isolate two dihydroxy acids from culture fil­
trates of strain 16117 of N. crassa. Adelberg and Tatum (1950) and Adelberg 
et al. (1951) identified the acids as alpha, beta-dihydroxyisovalerate 
(DHV, the dihydroxy acid precursor of valine), and alpha, beta-dihydroxy-
beta-methylvalerate (DHI, the dihydroxy acid precursor of isoleucine). 
The accumulation of the dihydroxy acids by mutant 16117 of crassa 
indicated that the mutant must be blocked prior to the formation of the 
keto acids. It was considered chemically possible that the keto acids 
could be precursors of isoleucine and valine, while a reaction that would 
allow the dihydroxy acids to be the immediate precursors was considered to 
be improbable. Therefore, Umbarger and Adelberg (1951) repeated the 
growth experiments with mutant 16117 in a medium containing enzymatically 
synthesized keto acids, and found that the mutant could utilize them in 
place of isoleucine and valine. A comparison of Bonner's synthetic KI 
with several other keto acids demonstrated that it was actually KB. 
Because they also found accumulations of DHV and DHI in culture filtrates 
of the mutant, they proposed that, while the biosynthesis of isoleucine 
and valine occurred in separate pathways, the final steps consist of the 
conversion of DHI (DHV) to KI (KV) to isoleucine (valine). 
An early step in the biosynthesis of isoleucine was indicated by Teas 
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(1948) and by Umbarger and Adelberg (1951). Both reports demonstrated 
that certain isoleucine-requiring mutants of E. coli could utilize KB for 
growth. Indirect evidence that KB was involved in the pathway was pro­
vided by isotope studies. Adelberg (1954) reported that C^^-1, 2-threo-
14 
nine was converted to C -1, 2-DHI by mutant 16117 of N. crassa and 
suggested that the biosynthesis of isoleucine involved deamination of 
threonine to form KB. Strassman et (1954) found carbon atoms from 
labeled acetate in isoleucine, and they suggested that a condensation of 
acetaldehyde with KB would form alpha-aceto-alpha-hydroxybutyrate (AHB), 
which would provide the carbon skeleton of isoleucine. 
Similar studies on the valine pathway were conducted by Strassman 
et al. (1953). They found that C^^-2, 3-valine was formed from C^^-2-
lactate, suggesting a condensation reaction involving two lactate mole­
cules. Additional isotopic studies by Abelson (1954) confirmed the role 
of KB in the synthesis of isoleucine and also indicated that pyruvate was 
involved in the synthesis of KV and valine. The results of Strassman 
et al. (1953) could be explained since it was known that pyruvate could 
be formed from lactate. 
These studies, indicating which compounds were possible intermediates 
in the biosynthesis of isoleucine and valine, were accomplished primarily 
by the use of isotopes and by identifying the compounds accumulated or 
utilized by mutants that required one or both of the amino acids. These 
data indicated a very close relationship between the isoleucine and valine 
biosynthetic pathways. However, the hypothesis (Bonner, 1946) that the 
accumulation of an intermediate in the Isoleucine pathway inhibited an 
analogous step in the valine pathway prevailed until studies on 
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Individual enzymes were reported. 
The transamination of the keto acid precursors of isoleucine and 
valine, which is the final step in the pathway, was the first reaction to 
be intensely studied at the enzyme level. Rudman and Meister (1953) puri­
fied two transaminases from extracts of E. coli strain W. Transaminase A 
catalyzed reversible reactions between alpha-ketoglutaric acid and either 
phenylalanine, tyrosine, tryptophan or aspartic acid. Transaminase B was 
apparently involved in the isoleucine-valine (ilv) pathway since it cata­
lyzed a reversible transamination between glutamate and the keto acid 
precursors of isoleucine, valine and leucine. In addition, each of the 
three amino acids could be used as the amino donor to the keto acid 
precursors of the other two amino acids. 
In the same study, these authors also investigated mutants of E. coli 
strain W that had an absolute requirement for isoleucine and a partial 
requirement for valine. Extracts of these mutants lacked transaminase B 
activity. However, another enzyme, which could use alanine or alpha-
aminobutyrate in a weak reaction with KV but not with KI, was purified 
from these extracts, which explained the absolute requirement for isoleu­
cine and the partial requirement for valine. The enzyme was also present 
in extracts of wild-type cells. The reaction was described as a non­
specific transamination (although KI was not an acceptor), and the authors 
concluded that a single enzyme, transaminase B, was primarily responsible 
for the transamination reaction in the ilv pathway. Similar observations 
were made on extracts of Salmonella typhimurium strain LT-2 (Wagner and 
Bergquist, 1960), indicating that Bonner's hypothesis was not correct 
since one enzyme could perform the transamination reaction for both 
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pathways, and the loss of this enzyme might block both pathways. 
These results indicated the presence of at least three distinct 
transaminases in coli and typhimurium. However, assays of crude 
extracts of N. crassa revealed at least four different transaminases, two 
of which required pyridoxal phosphate for activity (Fincham and Boulter, 
1956). Seecof and Wagner (1959a, 1959b) also found four transaminases in 
extracts of N. crassa. They purified a "phenylpyruvate transaminase" 
which formed isoleucine and valine from their keto acid precursors. They 
found, in contrast to the results obtained with transaminase B of coli, 
that at least ten amino acids could be used as amino donors in reversible 
reactions, and that the highest rate of transamination occurred with 
phenylalanine as the amino donor to KI. They concluded that a single 
enzyme, which displayed enhanced activity in the presence of pyridoxal 
phosphate, catalyzed the transamination of KI and KV, and that the trans­
aminases in coli and crassa differ in their patterns of specificity. 
The initial reaction in the biosynthesis of isoleucine was thought to 
be the deamination of threonine to form KB. An enzyme that could catalyze 
this reaction was purified from extracts of N. crassa (Yanofsky and 
Reissig, 1953). The "dehydrase" exhibited increased activity in the pres­
ence of pyridoxal phosphate and, while the enzyme demonstrated a higher 
rate of activity with threonine, it could also deaminate serine. Sayre 
and Greenberg (1956) reported similar results with a purified enzyme from 
extracts of sheep liver. They found that threonine deaminase (TD) activ­
ity was retained only when the concentration of phosphate buffer in the 
assay tubes was 0.05 M or greater, and that pyridoxal phosphate was 
required for maximal activity. Ultracentrifugation indicated that a single 
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protein was present In the purified preparation, but since the enzyme also 
weakly deaminated serine, they concluded that contamination with a serine 
deaminase had occurred, or that the TD could also react with serine. 
However, Umbarger and Brown (1956, 1957) found that threonine deami-
nation can be accomplished by more than one enzyme. They demonstrated 
the presence of two deaminases in crude extracts of strains W and K-12 of 
JE. coll. One of the enzymes is produced under anaerobic conditions and 
may be a degradative enzyme. The other deaminase, considered to be the 
biosynthetic enzyme, is produced only under aerobic conditions, is inhibi­
ted by isoleucine, and is absent in isoleucine-requiring mutants which can 
utilize KB for growth. The biosynthetic enzyme lost activity during 
storage under varied conditions and was unstable during ammonium sulfate 
precipitation, dialysis and incubation in the absence of substrate. How­
ever, both enzymes required pyridoxal phosphate and were active against 
threonine and serine. 
Isoleucine inhibits the activity of threonine deaminases of coli 
(Umbarger and Brown, 1958a), Saccharomyces cerevisiae (Kakar and Wagner, 
1964), S. typhimurium (Freundlich and Umbarger, 1963a; Maeba and Sanwal, 
1966), Mycobactarium tuberculosis (Âllaudeen and Ramakrishnan, 1968) 
Bacillus subtilis (Hayashibe and Uemura, 1961), Rhodopseudomonas capsulata 
(Hughes et al., 1964) and Rhodopseudomonas spheroides (Datta, 1966). In 
contrast, TD activity is weakly inhibited by isoleucine only at low sub­
strate concentrations in Rhodospirillum rubrum (Ning and Gest, 1966). 
However, the organism was grown under anaerobic conditions and the enzyme 
examined may have been the degradative TD. Leucine also inhibits TD 
activity in coli, but not as effectively as isoleucine, while valine 
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was reported to have no effect (Urabarger and Brown, 1958a). Similar 
results were obtained with extracts of cerevisiae (Kakar and Wagner, 
1964). However, Changeux (1963) reported that valine reversed isoleucine 
inhibition of TD activity in E. coli strain K-12, but, at concentrations 
above 0.01 M, valine was also inhibitory. 
Reports concerning stability of the biosynthetic TD in extracts of 
different organisms varied, but in all instances, there was a decrease in 
specific activity when extracts were prepared or assayed in solutions of 
low ionic strength. The TD of cerevisiae is very sensitive to dilution 
and is stabilized when stored at low temperature in 0.1 M phosphate buffer 
(De Robichon-Szulmajster and Magee, 1968). Harding (1969) reported that 
stability of the enzyme in extracts of JE. coli is greatly decreased at low 
enzyme concentration and is optimal at high (5 mM) substrate and phos­
phate buffer (0.5 M or higher) concentration. 
A comparison of the properties of threonine deaminases of different 
organisms show certain similarities. Enzyme activity is inhibited by iso­
leucine (except possibly in R. rubrum), is lost or greatly diminished in 
solutions of low ionic strength, is enhanced by pyridoxal phosphate and 
is observed with threonine or serine as substrates. 
Certain organisms convert acidic products to neutral products during 
glucose catabolism by a condensation reaction in which pyruvate and 
acetaldehyde form acetolactate (AL). Decarboxylation of the AL yields 
acetylmethylcarbinol (AMG) (Gale, 1947). Knowledge of this reaction led 
Umbarger et al. (1957) to investigate the possibility that such a conden­
sation might be involved in the formation of AL in the ilv pathway. They 
noted that a mutant of E. coli strain W accumulated AL when grown in a 
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medium containing limiting amounts of valine. Extracts of the mutant pro­
duced AL from pyruvate at approximately 10 times the rate of extracts of 
the parent strain. They also reported that valine inhibited the reaction. 
They proposed that AL is an intermediate in the valine pathway and that 
valine controls its own biosynthesis by a feedback inhibition of the 
enzyme that forms AL. 
Umbarger and Brown (1958b) also investigated the accumulation of AL 
by a mutant of E. coli, and found that the formation of the enzyme was 
repressed by valine, and valine was also an inhibitor of the reaction. 
The synthesis of AL by extracts of mutant and wild-type strains was opti­
mal at pH 8.0 in a phosphate-buffered system containing magnesium ions and 
thiamine pyrophosphate (TPP). 
These data strongly indicated that a condensation reaction similar 
to the one involved in glucose catabolism might also form AL in the valine 
pathway. This suggested that a single enzyme (or enzyme system) performs 
the condensation for valine biosynthesis and glucose catabolism, or that 
two enzymes are capable of the condensation reaction. Halpern and Umbarger 
(1959) investigated both possibilities in whole cells and crude extracts of 
Enterobacter aerogenes and obtained evidence that two enzymes are involved. 
One enzyme is optimally active at pH 7.5 and has properties similar to 
those found in coli. The other enzyme displays optimal activity at pH 
6.0, is only slightly stimulated by TPP, does not require magnesium ions, 
and valine does not affect either the formation or activity of the enzyme. 
However, extracts of cells grown at pH 5.8 had no AL-forming activity at 
pH 8.0, indicating that the system functioning at pH 6.0 provides AL for 
valine biosynthesis in cells grown at the lower pH. The condensation 
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reaction was further investigated by Leavitt and Umbarger (1961, 1962) in 
several strains of coli. Their results indicate that, in crude 
extracts, ÂL and ÀHB are formed by the same enzyme, since the formation 
of either intermediate is inhibited to the same degree by valine, is stimu­
lated by TPP and magnesium ions, has the same pH optimum, and shows the 
same loss in activity when the extracts are diluted or stored under varied 
conditions. In addition, the growth of strain K-12 is inhibited by valine 
but the growth of strain W is not. The authors demonstrated that the Al­
and AHB-forming system is more highly sensitive to valine in strain K-12 
than it is in strain W. 
The AL-forming system of typhimurium strain LT-2 was reported by 
Armstrong e^ al. (1963) to be different from the same system found in 
coli. They stated that the reaction had a pH optimum of 6.0 to 6.5 and 
was not inhibited by valine. However, Bauerle et (1964) demonstrated 
that the enzyme (the acetohydroxy acid synthetase, AAS) in strain LT-2 has 
a pH optimum of 8.0, and, at that pH, is inhibited by valine. They also ' 
found that the enzyme is unstable and requires, in addition to TPP and 
magnesium ions, an unidentified factor that could be supplied by boiled 
extracts of Salmonella or yeast. St^rmer and Umbarger (1964) identified 
the factor as flavine adenine dinucleotide (FAD). 
These data indicate that one enzyme, AAS, catalyzes the formation of 
both AL and AHB, but the evidence is not conclusive. Partial purification 
of the enzyme from extracts of N. crassa was accomplished, but the prepara­
tion had a pH optimum between 6.0 and 7.0, and, while activity was stimu­
lated by TPP and magnesium ions, formation of the enzyme was not affected 
by valine. In addition, crude extracts formed both AL and AMC, indicating 
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the presence of a decarboxylase (Radhakrlshnan and Snell, 1960). There­
fore, the enzyme may be similar to the pH 6.0 enzyme of aerogenes. 
Attempts to purify the AAS of coli and aerogenes were not suc­
cessful due to the instability of the enzyme. In addition, only mutants 
of N. crassa were shown to accumulate both AL and AHB or their decarboxy-
lated products (Wagner et al., 1959). The latter may be due to the activ­
ities of two different AL-forming enzymes in coli (Radhakrlshnan and 
Snell, 1960) and in aerogenes, one of which has a pH optimum of 6.0 
while the other has a pH optimum of 8.0. These organisms may have to lose 
the activities of both enzymes in order to show accumulations of AL and AHB. 
Inhibition of the activity of the AAS by valine has been reported in 
_E. aerogenes (Halpern and Umbarger, 1959), coli (Leavitt and Umbarger, 
1961, 1962), typhimurium (Bauerle et al., 1964), cerevisiae (Magee 
and De Robichon-Szulmajster, 1968a, 1968b), crassa (Radhakrlshnan and 
Snell, 1960), Pseudemonas aeruginosa (Varga and Horvath, 1967a), and M. 
tuberculosis (Allaudeen and Ramakrishnan, 1968). In all of these organ­
isms, except perhaps crassa, the enzyme was reported to be unstable, 
generally losing 30 to 50 per cent activity within 24 hours. However, the 
presence of FAD prevents heat inactivation of the AAS in 2» aeruginosa and 
may also decrease the loss of activity during attempts to purify the 
enzyme (Varga and Horvath, 1967a, 1967b). But, in addition to jP. aerugi­
nosa, the effects of FAD have apparently been investigated only in 
typhimurium (St^Srmer and Umbarger, 1964), a streptomycin-dependent mutant 
of coli (Desai and Polglase, 1965), and M. tuberculosis (Allaudeen and 
Ramakrishnan, 1968), with only the latter organism demonstrating no effect 
when the cofactor was added to assays of AAS activity. These reports did 
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not Include Investigations of the effects of FAD on AHB formation. 
Certain similarities in the properties of AAS activities in the organ­
isms listed above include: activity is enhanced by TPP and magnesium ions 
(and, in some instances, FAD), is optimal in phosphate-buffered systems, 
and is inhibited by valine. 
In the search for compounds that might be intermediates in the ilv 
pathway, a role for AL was suggested when it was shown to be converted to 
DHV by an extract of a mutant of coli (Umbarger et al., 1957), and to 
KV (in a reaction that indicated involvement of reduced triphosphopyridine 
nucleotide, TPNH) by an extract of cerevisiae (Strassman et al., 1958). 
The related compound, AHB, had been suggested as an intermediate in the 
biosynthesis of isoleucine (Strassman et , 1954). 
Confirmation that AL and AHB are intermediates was obtained by demon­
strating the conversion of both compounds to the dihydroxy acids in 
extracts of mutant 16117 of N. crassa (Wagner et al., 1958). However, as 
the authors pointed out, the reaction is a two-step process in which there 
is a repositioning of a methyl (or ethyl) group, and a reduction. If the 
rearrangement occurs first, alpha-keto-beta-hydroxyisovalerate (HKV) and 
alpha-keto-beta-hydroxy-beta-methylvalerate (HKI) would be intermediates 
in the synthesis of DHV and DHI, respectively. These keto-hydroxy acids 
(HKV and HKI) were synthesized and, in extracts of strain 16117, were con­
verted to the dihydroxy acids. The enzyme (the keto-hydroxy acid reduc­
tase) that catalyzes the reaction was active in crude and purified 
extracts of the wild-type strain, mutant 16117, and mutant 304 (which accu­
mulates AL and AHB) of crassa. These data suggest that two enzymes are 
involved in the conversion of AL and AHB to the dihydroxy acids. However, 
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attempts to Isolate HKV and HKI were unsuccessful, even when TPNH was 
omitted from the assays. These observations Indicate that the compounds 
exist only as enzyme-bound intermediates. 
Crude extracts of several strains of coli and aerogenes were 
also capable of converting AL and AHB to the dihydroxy acids (Umbarger et 
al., 1960). The authors demonstrated a correlation between TPNH oxidation 
and the appearance of the dihydroxy acids, which provided the basis for a 
spectrophotometric assay for oxidation of TPNH in the presence of AL or 
AHB. While reduction of HKV and HKI was also demonstrated, they suggested 
that a single enzyme performed the rearrangement and reduction of AL and 
AHB. 
Similar results were reported by Radhakrishnan ejt al. (1960) in crude 
extracts of E. coli and N. crassa. Using extracts of both organisms, how­
ever, these authors accomplished purification of the reductase as well as 
a reductoisomerase (RI), which converted AL and AHB to the dihydroxy acids. 
Extensive experimentation with the purified enzymes indicated that the 
reductase might not be involved in the ilv pathway, or that it might be an 
altered form of the RI. The latter was based on an observation that a 
purified RI with no initial reductase activity gradually gained reductase 
activity as it lost RI activity. Nearly identical results were obtained 
with a purified reductase and RI of typhimurium (Armstrong and Wagner, 
1961a, 1961b). 
However, the question concerning the involvement of one or two 
enzymes in the rearrangement and reduction steps has not been completely 
resolved. Some data indicate the participation of one enzyme which may 
exist in more than one form (possibly due to an alteration which does not 
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exist i^ vivo). But Allaudeen and Ramakrishnan (1968) found still a third 
enzyme, the acetohydroxy acid isomerase, in crude extracts of M. tubercu­
losis. The authors noted that the activity of the RI was enhanced by the 
presence of L-ascorbic acid. Therefore, TPNH was omitted in order to 
determine if ascorbic acid affected the isomerase step. From assays con­
taining ascorbic acid and either AL or ÀHB, either HKV or HKI was isolated 
and then converted to the corresponding dihydroxy acid. However, because 
the enzymes were not purified, these results only demonstrate that HKV and 
HKI can be formed, and that they can act as intermediates in the ilv path­
way. In addition, the data do not exclude the possibility that one enzyme 
can effect isomerization and reduction. Support for this possibility was 
obtained by Arfin and Umbarger (1969) who extensively purified a reducto-
isomerase from extracts of S^. typhimurium. The properties of the enzyme 
include the ability to perform the reverse isomerization of HKV to AL, 
reduce HKV to DHV, and form DHV from AL. No effect was noted when ascor­
bic acid was added to the assays. 
An additional difficulty in determining the properties of the RI and 
reductase is that some of the supporting and direct data were obtained in 
crude extracts by the spectrophotometric assay of Umbarger ejt al. (1960). 
The validity of the spectrophotometric assay of activity in crude extracts 
was questioned by Wagner et al. (1964) who demonstrated three distinct 
enzymes in N. crassa which oxidize TPNH in the presence of AL or AHB. 
Only one enzyme has the properties of the RI; the other two enzymes 
apparently are non-specific oxidases since they can perform the reaction 
with various other substrates. 
Therefore, the accumulated data indicate that one enzyme, the 
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reductolsomerase, accomplishes the over-all conversion of AL and AHB to 
the dlhydroxy acids. The enzyme requires magnesium ions and TPNH, and 
generally loses approximately 50 per cent activity in 24 hours in crude 
extracts. À reductase and an isomerase may exist as separate, distinct 
enzymes, but present evidence strongly suggest that at least one reduc­
tase is an altered form of the Rl. 
The remaining step in the ilv pathway is the conversion of the 
dlhydroxy acids (DHV and DHI) to the keto acids (KV and KI). Myers and 
Adelberg (1954) first demonstrated this conversion in crude extracts of 
E. coll and N. crassa. The enzyme, dlhydroxy acid dehydrase, was shown 
to require only magnesium ions for maximal activity in the presence of 
DHV or DHI. The enzyme is stabilized by cysteine, and activity is not 
inhibited by isoleucine or valine. These properties are also found for 
the dehydrase in crude extracts of S_. cerevislae (Wixom et , 1960). 
There is apparently only one report on the properties of a purified 
dlhydroxy acid dehydrase, which was presented by Myers (1961). The 
enzyme, which was purified from extracts of strain K-12 of JE. coli, 
utilizes both DHV and DHI as substrates. Indicating that a single enzyme 
is responsible for both reactions in the ilv pathway. Activity is opti­
mal in a trls-HCl buffer at pH 7.8, and is maximal in the presence of 
ferrous ions and a reducing agent (cysteine or glutathione). 
The intermediates in the ilv pathway have been identified and some 
of the properties of the enzymes which catalyze the reactions have been 
determined. Except for the deamination of threonine to form KB, each step 
in the biosynthesis of both isoleucine and valine is apparently catalyzed 
by a single enzyme, giving these enzymes bifunctional capabilities. 
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Regulation of the formation and activities of these enzymes poses a 
serious problem for living cells, since not only does the pathway involve 
the synthesis of isoleucine and valine, but the keto acid precursor of 
valine, KV, is an intermediate in the biosynthesis of leucine and panto­
thenate (Abelson, 1954; Ramakrishnan and Adelberg, 1964). This suggests 
that the regulatory mechanisms for the ilv pathway might be more complex 
than the mechanisms which would Influence a pathway with only one end-
product. 
Regulation of the ilv pathway is at least partially exerted by the 
end-products of the pathway; e.g., isoleucine inhibits the activity, and 
to a slight extent represses the formation, of the threonine deaminase 
of coli (Umbarger and Brown, 1958a), and valine inhibits the activity 
and represses the formation of the acetohydroxy acid synthetase of the 
same organism (Umbarger and Brown, 1958b). Repression of the formation 
of the ÂÂS is strongly indicated as a major factor in the inhibition of 
growth of strain K-12 of coli, since the enzyme is also involved in 
the biosynthesis of isoleucine. 
Inhibition of the growth of strain K-12 was reported by Cohen 
(1958) to be the result of the formation of "false protein". Addition 
of valine to an exponentially growing culture does not result in complete 
inhibition of growth, but does cause a decrease to a linear rate of 
growth. Under these conditions, Cohen concluded that valine is substi­
tuted for isoleucine in protein molecules, with the result that many of 
the fenzymes are inactive. However, Temple et al. (1965) not only demon­
strated that active enzymes are formed, but that the formation of induci­
ble enzymes could be accomplished during valine inhibition. They 
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concluded that valine acts by inhibiting the over-all rate of protein 
synthesis by preventing the biosynthesis of isoleucine. 
These results indicate that valine has an important role in regu­
lating the ilv pathway in the valine-sensitive strain of E^. coli. 
However, many bacteria are not inhibited by valine. Freundlich, Burns 
and Umbarger (1962) and Freundlich and Umbarger (1963b); demonstrated that 
in strain W of E, coli (which is not sensitive to valine) isoleucine, 
valine, leucine and pantothenate are necessary for maximal repression of 
the enzymes catalyzing the reactions of the ilv pathway. The authors 
termed this "multivalent repression". 
An additional aspect in regulation of the pathway was noted by 
Wagner and Bergquist (1963). They observed that the mitochondrial 
fraction of extracts of crassa could synthesize isoleucine and valine 
when supplied with KB, pyruvate and all of the cofactors necessary for 
each step. The supernatant fraction of the extracts also possessed all 
of the enzymes of the Ilv pathway. However, extracts of certain isoleu-
cine-valine requiring mutants of N. crassa, while demonstrating all of 
the enzymes in the supernatant fraction, could not perform the over-all 
synthesis with the mitochondrial fraction. Therefore, they suggested 
that the defect in these mutants is not due to an inability to produce 
active enzymes, but to an inability to organize them properly ^  vivo. 
Cronenwett and Wagner (1965) found that membrane fractions of extracts 
of typhimurium could synthesize isoleucine, but not valine, under simi­
lar conditions. 
These results indicate the complexity of the regulatory mechanisms 
operating in the ilv pathway. Enzyme inhibition and repression may be 
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accompanied by a necessity to organize the enzymes in a particular manner 
in order for the biosynthesis of isoleucine and valine to occur jji vivo. 
Roth and Sanderson (1966) determined the orientation of the struc­
tural genes that code for the enzymes of the ilv pathway in strain LT-2 
of typhimurium, and also suggested that the sequence is similar in 
strain K-12 of coli. Substituting the names of the enzymes for the . 
structural genes, the sequence is; transaminase, dehydrase, TD, RI, AAS. 
In addition, Ramakrishnan and Adelberg (1964) reported that the TD, 
dehydrase and transaminase are regulated by multivalent repression in 
strain K-12, but that the AAS and RI are not. They suggested that the 
TD, dehydrase and transaminase are in one operon, and that the AAS and 
RI are regulated by a separate operator gene. 
However, Smith and Pattee (1967) reported that the sequence of genes 
within the ilv pathway of strain 655 of Staphylococcus aureus is identi­
cal to the sequence in which the enzymatic reactions occur. This suggests 
that the mechanism by which the ilv pathway in aureus is regulated 
would be different from the method of regulation in strain K-12, because 
the structural genes in aureus could not be arranged in opérons in 
the same sequence as they are in strain K-12 of coli. Therefore, this 
study was undertaken in an attempt to determine the manner in which the 
ilv pathway is regulated in _S. aureus. 
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MATERIALS AND METHODS 
Media and Chemicals 
The media employed in this study included brain heart infusion 
(BHI, Difco), trypticase soy broth (TSB, Baltimore Biological Labora­
tories), and the synthetic medium of Kloos and Pattee (1965). The dere­
pression synthetic (DS) broth lacked isoleucine, valine and leucine, and 
the complete synthetic (CS) broth contained 30 >ig of isoleucine, 80 )ig of 
valine and 90 pg of leucine per ml. Unless otherwise stated, all com­
pounds employed throughout this study were the L-isomers. 
Alpha-ketobutyric acid (KB), the ethyl ester of alpha-acetolactic 
acid, alpha-ketoisovaleric acid (KV), and acetylmethylcarbinol (AMC) 
were obtained from Calbiochem. D, L-alpha, beta-dihydroxyisovaleric acid 
(D, L-DHV) was obtained from Reef Laboratories, Lafayette, Indiana, and 
L-alpha, beta-dihydroxyisovaleric acid (L-DHV) was kindly supplied by Dr. 
Frank Armstrong, North Carolina State University. All other reagents are 
commercially available. 
The free alpha-acetolactic acid (AL) was prepared from its ethyl 
ester by hydrolysis. The ester was slowly added with constant stirring 
to five ml of freshly-prepared 2 N NaOH in a beaker surrounded by an ice 
bath. Aliquots of the ester were dissolved in the solution until the pH 
was 7.0, after which the solution was diluted with H^O to achieve a final 
concentration of 100 juM of AL per ml. 
Alpha-naphthol was purified by sublimation and placed in a foil-
wrapped flask in a desiccator over CaClg and NaOH pellets. When stored 
in this manner, very little deterioration of the reagent occurred within 
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six months. The 2, 4-dinitrophenylhydrazlne was reprecipitated from hot 
ethyl acetate and stored in a similar manner. 
Bacterial Strains 
The majority of the experiments were performed with strain 655 of 
Staphylococcus aureus. In addition, strains 152 and U9 of S^. aureus 
were used in growth studies. These strains have been described previously 
(Pattee and Baldwin, 1961). Strain LT-2 of Salmonella typhimurium was 
used as a control in certain enzyme assays. 
Primary stock cultures of these strains were maintained at 4 C on 
BHI agar slants in screw-cap tubes and were transferred at three-month 
intervals. Secondary stock cultures were prepared by inoculating cotton-
stoppered BHI slants which were incubated at 37 C for 12 hours and then 
stored at 4 C. The secondary stock cultures were replaced each week. 
Growth Studies 
Growth curves 
All media used in the following procedures were prewarmed at 37 C 
unless otherwise indicated. Tubes containing 10 ml of DS broth were 
inoculated with cells of the appropriate strain of aureus and shaken 
in a water bath shaker (Warner-Chillcott Laboratories, Richmond, 
California, Model 2156) at a maximum setting of "10" at 37 C for 12 hours. 
The contents of the tubes were combined, and 2-ml aliquots were added to 
250-ml side-arm flasks containing 50 ml of DS or CS broth. Valine, leu­
cine or isoleucine, at final concentrations of 50, 100 or 500 ;ag per ml, 
were added to the flasks containing DS broth. These additions were made 
at the time of inoculation, or after the cultures had entered the log 
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phase of growth. The flasks were shaken at 37 C on a New Brunswick 
Platform Shaker at the minimal shaker setting of "one". Optical density 
(O.D.) readings were taken at appropriate Intervals on a Bausch and Lomb 
Spectronic 20 spectrophotometer at 535 mp. 
Repression and derepression studies 
To characterize the enzymes of the Isoleucine-vallne biosynthetlc 
pathway in strain 655, the cells were Inoculated into tubes of TSB and 
incubated at 37 C in a Warner-Chlllcott water bath shaker at a shaker 
setting of "10" for six hours. The TSB cultures were combined and used 
to inoculate Fernbach flasks containing from 500 to 1600 ml of DS broth. 
The initial O.D. of these flasks was approximately 0.15. The flasks were 
shaken at 37 C on a New Brunswick Platform Shaker at the minimal shaker 
setting of "one" until an O.D. of 1.15 to 1.3 was obtained (approximately 
5 hours). The cells were centrifuged at 10,000 rpm for 10 minutes in 
a Sorvall RC-2B centrifuge at 0-10 C, resuspended in cold 1 M phosphate 
buffer at pH 8.5 (hereafter referred to as phosphate buffer), centrifuged 
as above, weighed, and resuspended in phosphate buffer at a ratio of 
10 ml of buffer per gm wet weight of cells. All cell suspensions were 
frozen at -15 C until lysed, or were lysed immediately. Similar proce­
dures were employed to obtain cell suspensions of strain 655 grown in 
CS broth, DS broth containing 200 jug of valine per ml, CS broth containing 
240 jug of valine per ml, and CS broth containing 50 )x% of calcium panto­
thenate per ml. 
Cells were also grown in DS broth containing inhibitory concentra­
tions of isoleucine or leucine. Tubes containing 10 ml of TSB were 
Inoculated and Incubated as described above. Two Fernbach flasks. 
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containing 1600 ml of DS broth per flask, were each inoculated with 30 ml 
of the combined TSB cultures. The flasks were shaken as previously 
described until the O.D. reached 1.1 to 1.2. The cells were then har­
vested aseptically in a prewarmed (37 C) GSA rotor with the centrifuge 
chamber operating at room temperature. These cells, resuspended in 10 ml 
of DS broth, are referred to as the cell suspension in the following 
procedures. 
Four Fernbach flasks, each containing 1600 ml of DS broth, were each 
inoculated with 4.2 ml of the cell suspension (initial O.D. of approxi­
mately 0.55) and shaken at 37 C as previously described. One cell sample, 
which was later used to prepare the "0 hour" or control extract, was 
removed after one hour of incubation. Isoleucine, at a concentration of 
50 pg per ml of DS broth, was then added to each flask, and cell samples 
were removed each hour for four hours. The cells from each sample were 
collected by centrifugation in the cold (5 C) at 10,000 rpm for 10 
minutes. The cells were weighed, resuspended in phosphate buffer at a 
ratio of 10 ml of buffer per gm wet weight of cells, and frozen at -15 C. 
These procedures were repeated using leucine at a concentration of 200 
;ng per ml of DS broth. 
Preparation of cell-free extracts 
Three procedures were employed to lyse the cells. These included 
lysis with the staphylolytic enzyme (Burke and Pattee, 1967), and use of 
the Bronwill Tissue Homogenizer and the Bronwill Biosonik II. In the 
latter two procedures, the cell suspension was mixed with approximately 
two times its volume of 0.11-0.12 mm glass beads and cooled to 0-5 C. 
The cells were lysed by agitation for four minutes in the COg-cooled 
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chamber of the tissue homogenizer, or by sonlcation with the Biosonik II, 
using the standard probe at maximum power. For sonication, the cell-
glass bead suspension was placed in a glass beaker surrounded by an ice 
bath and sonicated at 20-second intervals for a total of six minutes of 
sonication. The procedure required approximately 25 minutes since one-
minute intervals were needed between periods of sonication to prevent 
heating of the probe and cell-glass bead suspension. 
The extract of the cells was separated from the beads by centrifu-
gation at 3,000 rpm for five minutes. The supernatant fluid was decanted 
and then centrifuged at 20,000 rpm for 15 minutes to remove whole cells 
and cellular debris. When the cells were lysed with the staphylolytic 
enzyme, only the second centrifugation was necessary. All centrifuga-
tions were accomplished at 0-10 C unless otherwise indicated. The 
protein concentration in the extracts was determined by the Biuret 
method, using 3 X recrystalized lysozyme as the standard. 
Enzyme Assays 
Threonine deaminase 
The standard threonine deaminase (TD) assay procedure was a modifi­
cation of the procedure of Umbarger and Brown (1957). The reaction mix­
ture contained 500 pM of phosphate buffer at pH 8.5, 20 ^ig of pyridoxal 
phosphate, 40 /iM of threonine and crude extract in a total volume of one 
ml in a Corex centrifuge tube. After incubation at 37 C for 30 minutes, 
the reaction was terminated by addition of one ml of 20 per cent tri­
chloroacetic acid. The tubes were centrifuged at 1500 x g for 10 minutes 
to remove precipitated material. 
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The supernatant fluid was assayed for the presence of KB by a modi­
fication of the procedures of Frledemann and Haugen (1943) and Sayre 
and Greenberg (1956). To 0.5 ml of the supernatant fluid was added 
0.5 ml of 0.1 per cent 2, 4-dinitrophenylhydrazine in 2 N HCl. The 
tubes were allowed to stand at room temperature for 5 minutes; one ml 
of 95 per cent ethyl alcohol was then added, followed by the addition 
of 2.5 ml of 2.5 N NaOH. The O.D. of the tubes was determined at 520 nyj 
after 10 minutes. 
Acetohydroxy acid synthetase 
The acetohydroxy acid synthetase (AAS) assay procedure was a modi­
fication of the procedures of Kakar and Wagner (1964) and St^rmer and 
Umbarger (1964). The standard assay solution contained 500 pM of phos­
phate buffer at pH 6.5 (which put the pH of the assay at 6.7 since the 
extract was prepared in 1 M phosphate buffer at pH 8.5), 200 >iM of Na 
pyruvate, 10 pM. of MgCl^, 80 pg of thiamine pyrophosphate (TPP), 4 pg 
of flavine adenine dinucleotide (FAD), and crude extract in a total 
volume of one ml in a Corex centrifuge tube. The tubes were incubated 
at 37 C for 30 minutes and the reaction was stopped by the addition of 
one ml of 20 per cent trichloroacetic acid. The tubes were then incu­
bated at 45 C for 30 minutes to ensure complete decarboxylation of AL to 
AMC (Radhakrishnan and Snell, 1960). 
The concentration of AMC in the tubes was determined by a modifica­
tion of the procedure of Westerfeld (1945). Each tube received the 
following; 2.6 ml of prewarmed (45 C) HgO; 0.4 ml of 2.5 N NaOH to 
neutralize the solution; one ml of prewarmed (45 C) 0.5 per cent creatine; 
one ml of a freshly-prepared alpha-naphthol solution (0.1 gm/2 ml of 
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2.5 N NaOH). The contents of each tube were uniformly mixed after each 
addition. The tubes were incubated at 30 C for 45 minutes, centrifuged 
at 1500 X g for 10 minutes, and the supernatant fluids were decanted into 
spectrophotometer tubes. The O.D. of each sample was determined at 530 
mp after a total of 60 minutes had elapsed since addition of the 
alpha-naphthol. 
Reduc to isomeras e 
The assay for reductoisomerase (RI) activity followed the procedure 
of Umbarger e^ al. (1960). Alpha-acetolactate reduction was correlated 
spectrophotometrically to oxidation of TPNH in a reaction mixture con­
taining 300 pM of phosphate buffer at pH 7.5, 10 pM of MgClg, 50 pM of 
neutralized AL, 0.5 pM of TPNH, and crude extract in a total volume of 
3 ml. The reagents, except TPNH, were added to a Quartz cuvette and 
incubated at 37 C for 10 minutes. Prewarmed (37 C) TPNH was added to 
the cuvette, the contents were rapidly mixed, and the oxidation of TPNH 
was recorded at 37 C on a Beckman DB recording Spectrophotometer at 
340 m^. A control tube, lacking substrate, was included in each assay to 
record non-specific oxidation of TPNH. 
Dihydroxy acid dehydrase 
The activity of the dehydrase in the cell-free extracts was deter­
mined by the procedure of Myers and Adelberg (1954). The Corex centri­
fuge tubes contained 100 pM of phosphate buffer at pH 8.0, 10 pM of MgSO^, 
15 pM of L-DHV, and crude extract in a total volume of 0.5 ml. The tubes 
were incubated at 37 C for 30 minutes and the reaction was terminated by 
the addition of 0.5 ml of 20 per cent trichloroacetic acid. The concen­
tration of KV in the assay tubes was determined by the procedures 
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described for the TD assay. 
Lactic dehydrogenase 
The standard assay for lactic dehydrogenase (LD) activity was a 
modification of the procedure of Nachlas et al. (1960). The assay tubes 
contained 700 pM of phosphate buffer at pH 9.0, 0.9 mg of DPN, 60 pM of 
Na lactate, and 0.1 ml of the crude extract in a total volume of one ml. 
The stock solutions of the substrate and DPN were prepared in 1 M phos­
phate buffer at pH 9.0. The reagents, except the enzyme, were added to 
Corex centrifuge tubes and incubated at 37 C for 10 minutes. After 
adding prewarmed (37 C) crude extract, each tube was incubated at 37 C 
for one minute. The reaction was stopped by the addition of one ml of 
20 per cent trichloroacetic acid. The concentration of pyruvic acid 
in the assay tubes was determined by the procedures described for the 
TD assay. 
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RESULTS 
Growth Curves 
A primary concern in this study was to determine the growth responses 
of strain 655 of Staphylococcus aureus to exogenous isoleucine, valine 
or leucine. As Illustrated in Fig. 2, 50 pg per ml of isoleucine or 
leucine added to DS broth at the time of inoculation were inhibitory, 
whereas 50 jug of valine per ml of DS broth did not decrease the growth 
rate. Isoleucine or leucine, at final concentrations of 100 pg per ml, 
exerted an inhibitory effect on exponentially growing cultures. This 
inhibition, also, was reversed by the addition of 100 jug of valine per 
ml four hours after the addition of isoleucine or leucine (Fig. 3). 
By repeating these experiments with strains U9 and 152 of aureus, 
it was determined that this growth response of strain 655 to exogenous 
isoleucine, valine and leucine was not unique to this strain. However, 
as identical results were obtained with all three strains, only the 
results obtained with strain 655 are presented. 
General Properties of the Enzymes 
Threonine deaminase 
Preliminary assays of threonine deaminase (TD) activity in crude 
extracts demonstrated that the enzyme was very unstable. Lysis of the 
cells or assay for TD activity in systems containing varied concentra­
tions of tris-HCl buffer, triethanolamine-HCl (TEA) buffer, or 0.1 or 
0.5 M phosphate buffer, all of which lacked or contained combinations of 
25 Jig of isoleucine per ml, 0.05 M mercaptoethanol, 0.1 M KCl or 20 pg 
of pyridoxal phosphate (PP) per ml, resulted in a 50 to 100 per cent loss 
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Fig. 2. Growth responses of strain 655 in CS broth (•)> DS broth (O ), 
and DS broth containing 50 fig per ml of isoleucine (A)> 
leucine (A), or valine (B). Conditions for growth are 
described in the text. 
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Fig. 3. Growth responses of strain 655 in DS broth. After 7.5 hr, 
100 )ig per ml of valine (B), leucine (O, • ) or isoleucine 
(A, A ) were added. After 11.5 hr, 100 pg per ml of valine 
(• , A ) were added. 
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in activity. However, an extract prepared in 0.5 M phosphate buffer con­
taining 0.1 M KCl and 25 pg of isoleucine per ml gave the most reproduci­
ble, although low, specific activity. Since isoleucine is an inhibitor 
of TD activity in many organisms, portions of the extract were dialyzed 
for six hours against phosphate buffers at concentrations of 0.1, 0.4, 
0.8 and 1 M. Subsequent assays demonstrated that the specific activity 
was enhanced in the extracts dialyzed against 0.8 and 1 M buffer. When 
an extract was prepared by lysing cells suspended in 1 M phosphate 
buffer, assays conducted immediately and after 10 hours demonstrated 
no differences in specific activities. 
A dilution effect was also noted in the TD assays. The specific 
activity of the TD decreased approximately 60 per cent in assay tubes 
containing a 1:20 dilution of the crude extract as compared to assay 
tubes containing a 1:10 dilution. Increasing the concentration of sub­
strate, PP, or phosphate buffer, or addition to the assay tubes of the 
supernatant fluid or the precipitate from boiled extract, or of bovine 
serum albumin dissolved in 1 M phosphate buffer did not diminish the loss 
in activity. Similar results have been reported for the TD of E^. coli 
(Harding, 1969), and of cerevisiae (De Robichon-Szulmajster and Magee, 
1968). 
The requirement for 1 M phosphate buffer to maintain TD activity 
interfered with attempts to purify the enzyme by ammonium sulfate 
precipitation, as .crystals of ammonium phosphate precipitated, and the 
enzyme was dispersed in the 40, 50 and 60 per cent ammonium sulfate 
fractions. Acetone precipitation of the enzyme caused a complete 
inactivation which was not reversed by extensive dialysis against 1 M 
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phosphate buffer. 
Subsequent studies demonstrated that the TD has a pH optimum of 8.5 
(Fig. 4) and is stable in 1 M phosphate buffer when stored at -15 C for 
as long as seven days. The enzyme is saturated at a substrate concen­
tration of 40 |iM of threonine. Fyridoxal phosphate is required for 
maximal specific activity; assay tubes lacking this cofactor exhibited 
a 25 to 30 per cent decrease in activity (Table 1). 
Table 1. Requirements for the enzymatic conversion of threonine to 
KB. In addition to the components listed in the table, 
each assay tube contained 40 pM of threonine and crude 
extract of strain 655 of aureus in a total volume of 
1.0 ml. The pH of the phosphate buffer was 8.5. The assay 
was conducted as described in Materials and Methods 
Additions 
Phosphate buffer Fyridoxal phosphate Specific activity 
(pM) (pg) QjM/mg protein/hr) 
0 0 2.48 
0 20 5.32 
100 20 9.92 
300 20 17.37 
500 20 19.67 
500 10 18.30 
500 0 14.36 
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too 
80 
60 
20 
8.0 9.0 7.5 8.5 6.5 7.0 6.0 
pH 
4. Determination of the pH optimum of the threonine deaminase 
(A)» acetohydroxy acid synthetase (O) and lactic dehydro­
genase (9) in 1 M phosphate buffer. The specific activities 
(pM/mg protein/hr) at the pH optimum for each enzyme were: 
TD - 24.4, AAS - 2.89, LD - 28.3 
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Acetohydroxy acid synthetase 
Initial attempts to obtain reproducible results with the acetohy­
droxy acid synthetase (AÂS) assay procedure of Kakar and Wagner (1964), 
as modified by St^rmer and Umbarger (1964), were unsuccessful. The 
preliminary assays indicated that at least part of the difficulty was 
due to the procedure (Westerfeld, 1945) involved in determining the 
concentration of acetylmethylcarbinol (AMC) in the supernatant fluid. 
Therefore, assays were conducted using the cofactors, known concentra­
tions of AMC, and bovine serum albumin. 
It was discovered that one cause of the variations in the assays 
was the use of commercial alpha-naphthol. This variable was eliminated 
by using alpha-naphthol that had been purified by sublimination under 
reduced pressure. In addition, it was noted that temperature played an 
important role, since temperatures below 25 C delayed development of 
color while temperatures above 45 C caused a change in color from the 
usual shade of red to a dark purple. This variable was minimized by 
first adding a constant amount (2.6 ml) of prewarmed (45 C) deionized 
HgO to each tube, and, after adding the remaining reagents, placing the 
tubes in a 30 C incubator for 45 minutes. Precipitated protein was removed 
by centrifugation. Assays conducted in this manner (with known concen­
trations of AMC) gave highly reproducible results. 
With a satisfactory assay procedure established to determine the 
concentration of AMC in the tubes, a series of experiments were conducted 
to determine the properties of the AAS. The enzyme was unstable when 
stored at 5 C or -15 C in any of the buffers that were employed in the TD 
assays or in the presence of 1 M phosphate buffer containing up to 800 ^g 
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of TPP per ml. However, the loss of activity, which amounted to 25 to 
40 per cent within 24 hours after preparation of the extract, was minimal 
in 0.5 or 1 M phosphate buffer. The instability of the enzyme required, 
therefore, that the AAS assay be conducted immediately after preparation 
of the extract. 
When dilutions were performed in 1 M phosphate buffer, all tubes 
corresponded very well with the tube containing the lowest dilution. 
However, when the extract was diluted prior to assay in 0.1 M phosphate 
buffer, 0.1, 0.2 or 0.5 M tris or TEA buffers lacking or containing 
0.05 M mercaptoethanol, 25 pg of isoleucine per ml, or 80 )ig of TPP per 
ml, an immediate and irreversible 25 to 90 per cent loss in specific 
activity occurred. 
As demonstrated in Fig. 4, the specific activity of the AAS is 
maximal at a pH of 6.7 to 6.8. The enzyme is saturated at a substrate 
concentration of 200 pM of pyruvate and, as indicated in Table 2, 
requires TPP, FAD and MgClg for maximum activity. It is also noted in 
Table 2 that a decrease in the concentration of phosphate buffer in the 
assay tubes from 500 to 0 ;liM resulted in a loss of approximately 16 per 
cent of the specific activity. 
Reductoisomerase 
Activity of the reductoisomerase (RI) was difficult to determine 
accurately since the highest concentration of TPNH that could be employed 
in the spectrophotometric assay was 0.7 /iM (yielding an initial O.D. of 
approximately 1.0), and the oxidation of TPNH was nearly complete within 
two minutes after adding the cofactor to the cuvette. The pH optimum for 
the assay was approximately 8.0, although repeated attempts, in a pH 
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Table 2. Requirements for the enzymatic conversion of Na pyruvate to 
alpha-acetolactate. In addition to the components listed in 
the table, each assay tube contained 200 pN of Na pyruvate 
and crude extract of aureus strain 655 in a total volume 
of 1.0 ml. The assay was conducted at pH 6.7 as described 
in Materials and Methods 
Additions 
TPP FAD MgCl, Phosphate buffer Specific activity 
(Pg) (pg) (pM) (pM) ()]M/mg protein/hr) 
0 0 0 0 0.87 
80 4 10 0 2.69 
80 4 10 100 2.84 
80 4 10 300 2.91 
80 4 10 500 3.21 
0 4 10 500 1.17 
80 4 0 500 2.76 
80 0 10 500 2.98 
range of 7.0 to 8.5, failed to show significant differences in specific 
activity. 
The results of Wagner et al. (1964) demonstrated that, in Neurospora 
crassa, the spectrophotometric determination of RI activity is not a 
valid assay since there are at least two other enzymes present in crude 
extracts that oxidize TPNH in the presence of alpha-acetolactate and 
several other substrates. Therefore, extracts of strain 655 of aureus 
and strain LT-2 of Salmonella typhimurium were assayed for oxidation of 
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TPNH using Na pyruvate, alpha-ketobutyrate (KB), or alpha-acteolactate 
(AL) or its ethyl ester as substrates. The procedures for the growth of 
strain LT-2 and the preparation of extracts were identical to the pro­
cedures described for strain 655. 
As indicated in Table 3, strain LT-2 oxidizes TPNH at a much greater 
rate than does strain 655. The results with strain LT-2 compare favor­
ably with those obtained by Armstrong and Wagner (1961a) using the same 
strain. In addition, strain 655 oxidizes TPNH in the presence of KB at 
approximately the same rate as in the presence of AL. These results 
indicate that oxidation of TPNH by extracts of strain 655 is not the 
result of activity of a substrate-specific enzyme, but may be the result 
of a nonspecific oxidase(s). 
Dihydroxy acid dehydrase 
The sample of the L-isomer of alpha, beta-dihydroxyisovaleric acid 
(L-DHV) supplied by Dr. Armstrong was sufficient to allow only a very 
limited characterization of the dehydrase. Assays conducted with the 
L-isomer demonstrated no loss in specific activity when extracts were 
prepared in 1 M phosphate buffer and stored at -15 C for up to one week. 
The specific activity was in the range of 10 to 12 pM of keto acid formed 
per mg of protein per hour when extracts were prepared from cells grown 
in DS broth. An assay conducted without MgSO^ indicated a loss of 32 per 
cent of specific activity. 
Assays of dehydrase activity employing D, L-DHV as substrate resulted 
in nearly complete inhibition of the enzyme. A loss of approximately 30 
per cent of the activity occurred in an assay mixture containing 15 ;jH 
of L-DHV and 22.4 ;jM of D, L-DHV. Extracts of typhimurium strain LT-2, 
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Table 3. Oxidation of TPNH by extracts of strain 655 of aureus and 
strain LT-2 of typhimurium. In addition to the substrates 
listed in the table, each assay tube contained 0.5 >iM of 
TPNH, 10 pN of MgClg, 300 pM of phosphate buffer at the pH 
indicated, and crude extract in a total volume of 3 ml. The 
assay was conducted as described in Materials and Methods 
Extract Substrate* pH 
Specific activity 
(;jM/mg protein/hr) 
I. Strain LT-2 AL 8.0 1.200 
AL 7.5 2.000 
AL (ethyl ester) 7.5 0.820 
KB 7.5 0.076 
II. Strain 655 AL 7.5 0.382 
AL 8.0 0.415 
AL 8.5 0.369 
KB 8.0 0.380 
• pyruvate 8.0 0.290 
AL (ethyl ester) 8.0 0.260 
^The concentration of all substrates was 50 pM. 
however, utilized both the L- and D, L-forms. 
D, L-DHV was synthesized by the procedures of Sjolander et al. 
(1954), but attempts to obtain the L-isomer by their quinine salt proce­
dure were unsuccessful. Use of the quinine salt procedure to isolate 
the L-isomer from D, L-DHV obtained from Reef Laboratories was also 
unsuccessful. A satisfactory grade of anhydrous quinine was not 
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available, which may have contributed to the lack of success In these 
procedures. 
Lactic dehydrogenase 
The activity of the lactic dehydrogenase (LD) was employed as a con­
trol to correlate the activities of the Isoleucine-vallne (ilv) enzymes 
to an enzyme unrelated to the ilv pathway. The initial assays of LD 
activity were conducted using the spectrophotometric method of Nachlas 
et al. (1960), which correlates the reduction of DPN to the production 
of pyruvate from lactate. However, the procedure of Friedemann and 
Kaugen (1943), which was used to determine the concentration of the keto 
acid end-product (KB) in the TD assay, could be used to determine the 
concentration of the keto acid end-product (pyruvate) in the LD assay. 
This procedure would minimize the amount of time required to perform both 
assays since they could be conducted simultaneously. Therefore, the 
activity of the LD in several crude extracts was determined by both pro­
cedures, and, as nearly identical results were obtained, the latter 
procedure was then routinely employed. 
The requirement for 1 M phosphate buffer to maintain TD activity pre­
cluded the use of other buffers in the preparation of extracts. However, 
phosphate buffers have a very limited buffering capacity at pH values 
above 8.5. While the pH optimum for LD activity in the presence of 1 M 
phosphate buffer was determined to be 9.0 (Fig. 4), assays were conducted 
with TEA buffers in a pH range of 8.8 to 9.6, and with phosphate and TEA 
buffers in concentrations of 0.1 to 1 M (Table 4). The results indicate 
that: a) increasing the concentration of TEA buffer from 0.2 to 1 M 
slightly decreases specific activity; b) the pH optimum in the presence 
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Table 4. The effects of concentration and type of buffer on the enzy­
matic conversion of Na lactate to pyruvate by crude extracts 
of strain 655 of aureus. In addition to the components 
listed in the table, each assay tube contained 60 of 
substrate and crude extract in a total volume of 1.0 ml. 
The assay was conducted as described in Materials and Methods 
Buffer 
Phosphate TEA^ PH DPN Specific activity 
(pM) (>iM) (mg) (pM/mg protein/hr) 
800 9.0 0.00 0.00 
700 9.0 0.90 21.10 
70 9.0 0.90 18.33 
140 —— 9.0 0.90 19.34 
350 —— 9.0 0.90 20.44 
0 ——— 8.5 0.90 17.94 
750 — 9.0 0.45 13.65 
—— 140 9.0 0.90 20.67 
——— 350 9.0 0.90 20.30 
——— 700 9.0 0.90 20.10 
— 140 8.8 0.90 20.00 
—— 140 9.2 0.90 20.54 
— 140 9.6 0.90 20.20 
^Triethanolamine-HCl buffer. 
of TEA buffer is approximately 9.0; c) activity is slightly enhanced in 
the presence of 1 M phosphate buffer. Therefore, in order to prevent 
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possible pH changes In the assays, stock solutions of substrate and DPN 
were prepared in 1 M phosphate buffer at pH 9.0. 
Optimal activity was obtained at a substrate concentration of 60 pM 
of Na lactate and a DPN concentration of 0.9 mg. Increasing the concen­
tration of substrate or cofactor did not significantly increase activity, 
while assays conducted without DPN demonstrated no activity. No loss 
in LD activity was noted in extracts stored at -15 C for as long as one 
week. 
Preparation of Extracts 
Cell-free extracts, obtained by lysing the cells with the staphy-
lolytic enzyme, lacked TD activity since the staphylolytic enzyme is opti­
mally active in 0.1 M TEA buffer and is inhibited by 1 M phosphate buffer 
(Burke and Pattee, 1967). Cells suspended in 0.1 M TEA and lysed with 
the staphylolytic enzyme failed to yield an active TD even when the 
preparation was diluted with an equal volume of 2 M phosphate buffer 
immediately after lysis. 
Sonication proved to be the most convenient method for lysing cells 
of aureus. The Bronwill Tissue Homogenizer required less time, but 
it was difficult to control temperature during lysis, and cell suspen­
sions with volumes of less than 15 ml could not be used with this 
instrument. As sonication did not present these disadvantages, it was 
routinely used to prepare the cell-free extracts. 
Since it was not possible to lyse all cell suspensions immediately 
after harvesting the cells, the specific activities of the enzymes were 
determined, in crude extracts prepared from fresh and frozen cells. Cells 
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grown in DS broth were resuspended in cold (5 C) phosphate buffer and 
divided into three equal volumes. One of the cell suspensions was lysed 
and assayed immediately, and the other two suspensions were frozen at 
-15 C. A second suspension was lysed and assayed after being frozen for 
six days, and the third suspension was lysed and assayed after being 
frozen for ten days. No differences were noted in the specific activi­
ties of the TD, AAS or LD enzymes in any of the extracts. 
Inhibition of the Enzymes ^  Vitro 
The stock solutions of valine, leucine, isoleucine, KV and calcium 
pantothenate employed in the ijn vitro inhibition studies were prepared 
in 1 M phosphate buffer at the pH optimum for the particular enzyme. 
This prevented a decrease in the concentration of the buffer in the 
assays. The stock solutions were kept frozen at -15 C in sealed screw-
cap tubes until used, and were not sterilized in order to prevent possible 
changes in concentration. 
Threonine deaminase 
Inhibition of TD activity occurred in the presence of either isoleu­
cine, valine or leucine. The enzyme was most sensitive to inhibition 
exerted by isoleucine, with a concentration of 0.5 pM yielding approxi­
mately 50 per cent loss in specific activity in extracts of cells grown 
in DS broth (Fig. 5). In contrast, the same extract yielded a 50 per cent 
loss in specific activity in the presence of approximately 21 ;iM of 
leucine (Fig. 6), and 100 pM of valine resulted in only a 22 per cent loss 
in specific activity (Fig. 7). However, valine reversed the inhibition 
exerted by isoleucine (Fig. 8) and by leucine (Table 5). The level of 
Fig. 5. Inhibition exerted by isoleucine on TD activity in crude 
extracts obtained from cells grown in DS (#) and CS 
(O) broth. Control tubes lacking isoleucine had specific 
activities of 21.8 ;yiM and 2.84 pM per mg of protein per 
hr, respectively 
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Fig. 6. Effects of leucine on TD activity in crude extracts obtained 
from cells grown, in DS (•) and CS (O) broth. Control tubes 
lacking leucine had specific activities of 21.8 and 2.84 
pM per mg of protein per hr, respectively 
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Table 5. The effects of increasing valine concentration on the inhibi­
tion, exerted by leucine, of TD activity 
Leucine 
concentration 
(pM) 
Valine 
concentration 
(pM) 
Specific 
.activity 
(pM/mg/hr) 
Per cent loss in 
specific activity 
0 0 21.51 0.0 
5 0 16.78 22.0 
5 10 18.20 15.4 
10 0 14.42 33.0 
10 10 16.33 24.1 
10 20 17.98 16.4 
inhibition exerted by isoleucine was also reversed by increasing the sub­
strate concentration (Table 6). No loss in activity resulted from the 
addition of 1 to 10 pM of calcium pantothenate. 
In order to determine whether growth of the cells in the presence of 
isoleucine, valine and leucine would alter the in vitro responses of the 
TD, MS and LD enzymes to the three amino acids, a crude extract of cells 
grown in CS broth was prepared. As illustrated in Fig. 5, the in vitro 
response of the TD to isoleucine differed very little, whereas the inhi­
bition exerted by leucine (Fig. 6) and valine (Fig. 7) decreased. It was 
also noted that the specific activity of the TD in crude extracts of cells 
grown in DS broth (21.8 jaM/mg protein/hr) was nearly eight times greater 
than the specific activity of the TD in the crude extracts of cells grown 
in CS broth (2.84 pM/mg protein/hr). 
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Table 6. The effects of increasing substrate concentration on the 
inhibition, exerted by Isoleuclne, on TD activity 
Threonine Isoleuclne Specific Per cent loss in 
concentration concentration activity specific activity 
(pM) (pM) (pM/mg/hr) 
40 0 18.25 0.0 
80 0 18.45 0.0 
120 0 18.60 0.0 
40 5 2.66 85.4 
80 5 7.62 58.3 
120 5 13.64 25.3 
40 10 2.48 86.4 
80 10 7.09 61.1 
120 10 10.45 42.7 
40 20 2.66 85.4 
80 20 7.09 61.1 
120 20 10.19 44.2 
Acetohydroxy acid synthetase 
All assays of acetohydroxy acid synthetase (AÂS) activity were per­
formed immediately after preparation of the extracts due to the insta­
bility of the enzyme. Inhibition of AAS activity occurred in the presence 
of Isoleuclne, valine, leucine and alpha-ketoisovalerate (KV). The 
enzyme was most sensitive to inhibition by KV, demonstrating an average 
loss of 50 per cent in specific activity at a concentration of 20 pM in 
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extracts of cells grown in DS broth (Fig. 9). The same extracts lost an 
average of 17.5 per cent in specific activity in the presence of 20 /aM 
of valine (Fig. 9), 15 per cent in specific activity in the presence of 
20 pM of isoleucine, and 11 per cent in the presence of 20 pM of leucine 
(Fig. 10). It was not possible to increase the concentration of iso­
leucine or leucine above 50 pN in the assays because of the limited 
solubility of these amino acids in 1 M phosphate buffer. No loss in 
AAS activity resulted from the addition of 1 to 10 of calcium panto­
thenate or of 40 pM. of threonine. 
AAS activity was inhibited by isoleucine and valine to the same 
extent in extracts of cells grown in DS or CS broth. However, the 
extract of cells grown in CS broth yielded a higher degree of inhibition 
of AAS activity by KV (Table 7). In addition, increasing the substrate 
concentration did not affect the inhibition exerted by valine or leucine, 
but did decrease the level of inhibition exerted by KV (Table 8). 
Several attempts to determine the degree of inhibition exerted by 
combinations of KV, isoleucine, valine or leucine on AAS activity yielded 
results that were quite variable, but in no instance did the presence of 
one compound reverse the inhibition exerted by another. In addition, the 
combined effects of any two or three of the compounds were not additive, 
e.g.; the per cent inhibition exerted by a combination of 10 )M of iso­
leucine and 10 of KV was lower than the sum of the per cent inhibitions 
exerted by the compounds separately at the same concentration. 
Lactic dehydrogenase 
The specific activity of the lactic dehydrogenase was not diminished 
by isoleucine, valine, leucine, threonine, KV or calcium pantothenate at 
Fig. 9 Effects of valine (•) and KV (O) on AAS activity in extracts 
of cells grown in DS broth. Each point in the curves is the 
average of 2 to 4 assays 
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Fig. 10. Effects of isoleucine (O) and leucine (O) on ÀÂS activity 
in extracts of cells grown in DS broth. Each point in the 
curves is the average of 3* to 4 assays 
Table 7. A comparison of the level of inhibition exerted by isoleucine, valine and alpha-
ketoisovalerate (KV) on AAS activity in extracts of cells grown in CS broth and in 
DS broth. Specific activity is defined as pM of product formed per mg of protein 
per hr 
Extract from repressed cells^ Extract from derepressed cells^ 
Additions 
Specific activity 
(pM) 
Per cent loss in 
specific activity 
Specific activity 
(pM) 
Per cent loss in 
specific activity 
None 3.30 0.0 3.10 0.0 
Isoleucine 
(30 jjM) 2.55 22.7 2.48 20.0 
Isoleucine 
(50 jjM) 2.34 29.1 2.08 32.9 
Valine 
(25 pM) 2.65 20.0 2.46 20.6 
Valine 
(50 ;iM) 2.38 27.9 2.22 28.4 
KV 
(10 pM) 1.69 48.8 2.34 24.8 
^Extract of cells grown in CS broth. 
^Extract of cells grown in DS broth. 
Table 7. (Continued) 
Extract from repressed cells^ Extract from derepressed cells^ 
Specific activity Per cent loss in Specific activity Per cent loss in 
Additions (pM) specific activity (pM) specific activity 
KV 
(20 ;iiM) 1.11 66.3 1.75 43.0 
KV 
(30 pM) 0.81 75.5 1.51 50.2 
Table 8. The effects of increasing substrate concentration on the inhibition of AAS activity by 
isoleucine, valine or KV. The specific activity is defined as pM of product formed per 
mg of protein per hr 
Additions to the assay 
Pyruvate Per cent loss in 
concentration Isoleucine Valine KV Specific activity specific activity 
(pM) (pM) (joM) (jiM) 
200 — —• —— 2.56 0.0 
400 —— —— —— 2.62 0.0 
600 — —— —— 2.65 0.0 
200 30 —— —- 1.99 22.3 
400 30 — —— 1.95 25.8 
600 30 —— — 1.96 24.7 
200 75 1.66 35.2 
400 —— 75 1.67 36.1 
600 —— 75 1.71 35.4 
200 25 1.19 53.5 
Table 8. (Continued) 
Additions to the assay 
Pyruvate 
concentration 
(pM) 
Isoleucine 
(HM) si (D KV (pM) Specific activity Per cent loss in specific activity 
400 -- — 25 1.46 44.4 
600 mm 25 1.85 30.2 
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concentrations similar to those employed for the inhibition studies with 
TD and AAS enzymes. 
Repression and Derepression Studies 
Since isoleucine and leucine demonstrated inhibitory effects on the 
growth of strain 655, and valine reversed this inhibition (Fig. 2 and 3), 
a comparison was made of the specific activities of the TD, AAS and LD 
enzymes in extracts of cells grown in DS and CS broth. As demonstrated 
in Table 9, growth in the presence of isoleucine, valine and leucine (CS 
broth) resulted in a severely decreased level of TD activity, but little 
change in AAS or LD activities. 
However, In order to follow more closely the effects of isoleucine, 
valine and leucine on the levels of the activities of these enzymes, an 
additional experiment was performed. As Illustrated in Fig. 11, two 
flasks (3200 ml) of CS broth were Inoculated with cells grown in TSB. 
The two flasks (and all other flasks in this experiment) were shaken at 
37 C on a New Brunswick Platform Shaker, and the cells were harvested 
aseptlcally by centrifugation when the O.D. of the flasks reached 1.2 
(4.5 hours of incubation). An aliquot of the resuspended cells was used 
as the control or "0 hour repressed cells". The remaining cells were 
used to inoculate six flasks (9,000 ml) of DS broth. These flasks were 
Incubated for four hours, and a cell sample was removed each hour. The 
fourth-hour sample was harvested aseptlcally, with 10 ml of the resus­
pended cells used as the "derepressed cells". Four flasks (6,000 ml) of 
CS broth were Inoculated with the remaining cells. These flasks were 
Incubated for four hours and a cell sample was removed each hour. The 
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Table 9. Â comparison of enzyme activities in extracts of cells grown 
in synthetic media supplemented as indicated in the table. 
Growth conditions and assay procedures are described in 
Materials and Methods 
Specific activity 
(jiM/mg proteln/hr) 
Synthetic 
media 
Threonine 
deaminase 
Acetohydroxy 
acid synthetase 
lactic 
dehydrogenase 
DS broth 19.67 3.17 27.80 
CS broth 2.93 3.25 28.60 
CS broth with 50 
pg per ml of 
pantothenate 4.46 2.65 29.40 
DS broth with 200 
}ig per ml of 
valine 9.29 3.89 38.66 
CS broth with 240 
pg per ml of 
valine 13.94 2.72 28.91 
O.D. of each flask, and the results of the assays conducted on extracts 
of the cell samples are presented in Table 10. As indicated, the activity 
of the TD increased with time in cells grown in DS broth, and decreased 
with time in cells grown in CS broth. 
There were only slight variations in the activity of the AAS in all 
extracts, but these variations indicate that the AAS was repressed 
slightly with time in cells grown in DS broth, and was derepressed to a 
very limited degree with time in cells grown in CS broth. The LD activ­
ity remained relatively constant throughout these procedures. 
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TSB Cultures 
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es Broth 
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u 
DS Broth 
Cell sample removed each hr to determine the 
rate of derepression of the TD and AÂS 
V 
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37 C 
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V 
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of the TD and AAS 
37 C 
4.0 hr 
Fig. 11. Summary of procedures used for the growth of strain 655 of 
aureus in CS broth with sequential transfer of cells to 
DS broth and then to CS broth 
Table 10. The specific activities of the TD, MS and LD enzymes in extracts of cells grown in CS 
broth with sequential transfer to DS broth and then to CS broth. The O.D. of each 
flask was determined each time a cell sample was removed 
Specific activity (pM/mg/hr) 
Medium Time* Ave.^ 
O.D. 
Threonine 
deaminase 
Acetohydroxy 
acid synthetase 
Lactic 
dehydrogenase 
I. DS broth 0 hr^ 1.20 2.84 3.83 28.73 
1 hr 0.63 6.46 3.61 30.44 
2 hr 0.75 8.18 4.05 26.58 
3 hr 0.86 9.84 3.00 29.73 
4 hr** 1.10 12.48 2.73 30.19 
^ours after inoculation of the flasks. 
Average optical density of the flasks. 
Scells used to inoculate the DS broth. The cells had been grown in CS broth and represent 
"repressed cells". 
cells. 
A sample of these cells were used to inoculate the CS broth and represent the "derepressed 
Table 10. (Continued) 
Specific activity (jiM/mg/hr) 
Medium Time' Ave. 
O.D. 
Threonine Acetohydroxy Lactic 
deaminase acid synthetase dehydrogenase 
II. CS broth 1 hr 
2 hr 
3 hr 
4 hr 
0.65 
0.85 
1.10 
1.26 
11.54 
8.08 
4.00 
2.14 
2.92 
3.22 
3.16 
3.32 
27.84 
27.64 
26.52 
29.90 
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Valine reversed the inhibition exerted by isoleucine and leucine on 
the growth of strain 655 (Fig. 3), and also reversed the inhibition 
exerted by isoleucine on the activity of the TD in vitro (Fig. 8). To 
determine whether an excess of valine in the growth medium would affect 
the synthesis of the enzymes, extracts were prepared of cells grown in 
CS broth containing 240 pg of valine per ml, and in DS broth containing 
200 }ig of valine per ml. In addition, the effects of pantothenate (which 
is synthesized from KV) on the levels of the enzymes were determined by 
conducting assays on an extract of cells which had been grown in CS 
broth containing 50 pg of calcium pantothenate per ml. As shown in 
Table 9, synthesis of the AAS was repressed in cells grown in CS broth 
containing pantothenate or an excess of valine, and was maximally dere-
pressed in cells grown in DS broth containing an excess of valine. 
However, synthesis of the TD was repressed by approximately 50 per cent 
in cells grown in DS broth containing an excess of valine, was severely 
repressed in cells grown in CS broth containing pantothenate, and was only 
slightly repressed in cells grown in CS broth containing excess valine. 
LD activity remained constant except in the extract of cells grown in DS 
broth containing an excess of valine, where LD activity was significantly 
increased. 
The specific activities of the enzymes in extracts of cells grown in 
DS broth containing inhibitory concentrations of either isoleucine (50 yig 
per ml) or leucine (200 pg per ml) were also determined. The inhibition 
required that the flasks be inoculated with sufficient cells to obtain a 
high initial O.D. (approximately 0.57), and the flasks were incubated for 
one hour before adding the amino acid. The O.D. of each flask was 
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determined as each cell sample was removed. As indicated in Table 11, 
the synthesis of both the TD and the AÂS was repressed significantly with 
time in cells grown in the presence of either isoleucine or leucine. 
However, full repression of either enzyme was not obtained in any of the 
extracts. The LD activity remained relatively constant with time in 
all extracts. À fourth-hour sample was not obtained from the flasks con­
taining leucine because the O.D. indicated that the cells might have 
entered the stationary phase. 
Table 11. The specific activities of the TD, AAS and LD enzymes in extracts of cells grown in DS 
broth containing isoleucine or leucine. The O.D. of each flask was determined each 
time a cell sample was removed 
Specific activity (pM/mg/hr) 
Mediua Time* Ave.^ 
O.D. 
Threonine 
deaminase 
Acetohydroxy 
acid synthetase 
Lactic 
dehydrogenase 
DS broth with 
50 ;ig per ml 
of Isoleucine 0 hr 0.72 15.47 3.94 30.87 
1 hr 0.82 12.59 3.18 27.41 
2 hr 0.90 11.33 2.82 27.00 
3 hr 0.96 11.02 2.83 23.94 
4 hr 1.02 10.40 2.61 32.40 
I. 
^Hours after addition of isoleucine or leucine. 
^The average of the optical densities of the flasks. 
Table 11. (Continued) 
Specific activity (pM/mg/hr) 
Medium Time' Ave. 
O.D. 
Threonine Acetohydroxy Lactic 
deaminase acid synthetase dehydrogenase 
II. DS broth with 
200 pg per ml 
of leucine 0 hr 
1 hr 
2 hr 
3 hr 
0.69 
0.86 
1.02 
1.15 
15.12 
11.00 
7.74 
7.00 
3.84 
2.74 
2.48 
2.35 
31.20 
28.14 
24.00 
28.35 
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DISCUSSION 
The growth of strain W of Escherichia coll is not affected by iso-
leucine, valine or leucine. However, strain K-12 of JE. coll differs 
in that growth is inhibited by valine, and isoleucine reverses this 
inhibition. As demonstrated in this study, three strains of Staphylo­
coccus aureus respond in still a different manner to exogenous isoleu­
cine, valine and leucine (Fig. 2 and 3). These data demonstrate that: 
a) each strain is able to grow in synthetic broth lacking isoleucine, 
valine and leucine (DS broth); b) addition of either isoleucine or leu­
cine to DS broth inhibits growth; c) valine reverses the inhibition 
exerted by isoleucine or leucine; d) addition of valine does not decrease 
the growth rate. These data suggest that regulation of the ilv pathway 
in aureus may include a feedback inhibition exerted by isoleucine and 
leucine. Therefore, studies were conducted to determine the in vitro 
effects of isoleucine, valine and leucine on the enzymes of the ilv 
pathway. 
As previously stated, attempts to characterize the reductolsomerase 
(RI) of strain 655 were unsuccessful because of an apparent non-specific 
oxidation of TPNH in the presence of several substrates. In addition, 
the limited supply of L-DHV allowed only a preliminary investigation of 
the properties of the dihydroxy acid dehydrase. However, the results 
demonstrate that the dehydrase is specific for the L-isomer of DHV, as 
the activity of the dehydrase is completely inhibited by D, L-DHV. The 
D, L-DHV was utilized as substrate by extracts of Salmonella typhimurlum, 
indicating that the racemic mixture is biologically active in this system. 
71 
The assays of threonine deaminase (TD) activity Indicate that the 
properties of the TD of strain 655 do not differ significantly from the 
properties of the analogous enzyme of other organisms. The activity of 
the TD is inhibited by isoleuclne and leucine, while valine, which 
exerts slight inhibition only at relatively high concentrations, rever­
ses the inhibition exerted by isoleuclne and leucine. 
In contrast, numerous differences have been reported for the proper­
ties of the acetohydroxy acid synthetase (ÂÂS) of various organisms. An 
example is the acetolactate-forming system of Enterobacter aerogenes, 
which exhibits pH optima of 6.0 and 7.5. The pH 7.5 enzyme is inhibited 
by valine and is considered to be active in the biosynthesis of this 
amino acid. The pH 6.0 enzyme is not affected by valine and is consi­
dered to be involved in glucose catabolism (Halpern and Umbarger, 1959). 
In contrast to aerogenes, Neurospora crassa possesses only one AAS, 
which has a broad pH optimum of 6.0 to 7.0 and is not inhibited by valine 
(Radhakrishnan and Snell, 1960). The AAS of Mycobacterium tuberculosis 
has a pH optimum of 6.9, and does not have a requirement for FAD, but 
valine does inhibit activity (Allaudeen and Ramakrlshnan, 1968). 
The AAS of strain 655 has a pH optimum of 6.7 (Fig. 3), which is 
intermediate between the pH optima of 6.0 and 7.5 found for the two 
acetolactate-forming systems of aerogenes. Indirect evidence* that 
the AAS is Involved in valine biosynthesis is provided by two observa­
tions. First, the acetolactate (AL) formed in the assays is not con­
verted to acetylmethylcarbinol (AMC) without acid treatment. This 
suggests that the acetolactate-decarboxylase, which is active in producing 
AMC spontaneously during glucose catabolism (Radhakrishnan and Snell, 
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1960), is not active in strain 655 under the assay conditions employed in 
this study. Secondly, isoleucine, valine, leucine and alpha-ketoiso-
valerate (KV) inhibit the activity of the AAS (Fig. 9 and 10), and it 
is doubtful that an enzyme which is not involved in the ilv pathway 
would be inhibited by these compounds. 
In jî. coll, the AAS of strain K-12 has been found to be more sensi­
tive to valine than is the AAS of the vallne-resistant strain W. 
Leavitt and Umbarger (1962) suggested that the increased sensitivity of 
the AAS of strain K-12 is the cause of the inhibition of growth of this 
strain in the presence of valine. However, the Inhibition is not com­
plete, but results in a decrease from an exponential to a linear rate of 
growth. Cohen (1958) attributed the linear rate of growth to the syn­
thesis of false protein formed by the incorporation of valine in place 
of isoleucine. Temple et al. (1965) obtained contradictory evidence 
when they demonstrated that the activities of certain enzymes did not 
decrease when strain K-12 was grown in the presence of valine. They 
suggested that the linear rate of growth may be an artifact created by 
the method of depicting a decreasing exponential growth. 
A similar decrease in the rate of growth of strain 655 occurs in 
the presence of Isoleucine and, to a lesser extent, leucine (Fig. 3). 
However, as indicated in Table 11, ths activities of the AAS and TD 
enzymes decreased in extracts of cells grown in DS broth containing iso­
leucine or leucine, but the activity of the lactic dehydrogenase (ID) 
remained nearly constant. These data indicate that either isoleucine or 
leucine represses formation of the AAS and TU, but the two amino acids do 
not substitute for valine in the LD. Therefore, it is unlikely that the 
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decrease in the rate of growth of strain 655 in the presence of isoleu-
cine or leucine is the result of the formation of false protein. 
Freundlich et al. (1962) and Freundlich and Umbarger (1963b) 
reported that maximum repression of the enzymes of the ilv pathway in 
strain W of coli and strain LT-2 of typhimurium occurs when each 
of the end-products, isoleucine, valine, leucine and pantothenate, is 
present in excessive concentrations. This pattern of control by end-
products of the enzymes involved in a biosynthetic pathway has been 
termed "multivalent repression". 
Several experiments were conducted to determine whether multivalent 
repression is exerted on the TD and AÂS of strain 655. The activities 
of the TD, AAS and LD in these procedures were compared to the activities 
obtained in an extract of cells grown in DS broth. The results of these 
experiments (Table 9) indicate that formation of the TD and the AAS is 
not affected to the same degree, nor in the same manner, in cells grown 
in various synthetic media. TD synthesis was maximally repressed (85 
per cent loss in specific activity) in cells grown in CS broth, or CS 
broth containing pantothenate (77 per cent loss in activity), and was 
moderately repressed in cells grown in CS or DS broth containing an excess 
of valine. The latter two observations correlate with the data obtained 
from assays of TD activity in vitro, as valine, by itself, was slightly 
inhibitory, but also decreased the level of inhibition exerted by leucine 
and isoleucine. In addition, growth of the cells in DS broth containing 
isoleucine or leucine did not completely repress the TD (Table 11). 
Therefore, while the presence of pantothenate had little effect, these 
data indicate that repression of the TD is regulated by a mechanism 
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similar to multivalent repression, but requiring that all three amino 
acids be present in a particular ratio. 
In contrast, AÂS formation was not affected in cells grown in CS 
broth containing pantothenate, decreased with time in cells grown in DS 
broth containing isoleucine or leucine, was enhanced in cells grown in 
DS broth with an excess of valine, but was decreased in cells grown in 
CS broth containing an excess of valine. The latter two observations 
indicate that valine (at this relatively low concentration as compared 
to the concentration needed for inhibition of the AAS ûi vitro) may stim­
ulate AAS synthesis in vivo, but, in conjunction with isoleucine and 
leucine, represses the AAS when present at a concentration three times 
greater than is used in CS broth. In addition, the increase in AAS 
synthesis in cells grown in DS broth containing an excess of valine may 
explain why the rate of growth of strain 655 is optimal in DS broth con­
taining valine (Fig. 2). 
These results indicate that AAS synthesis is maximally repressed 
by pantothenate or a combination of the three amino acids and pantothe­
nate, but not to a degree (16 per cent loss in specific activity) which 
is consistant with the concept that a mechanism similar to multivalent 
repression would be an effective regulator of AAS formation. 
In order to further examine the patterns of repression and dere­
pression of the TD and the AAS, strain 655 was grown in CS broth with 
sequential transfer to DS broth and then to CS broth (Fig. 11). The data 
in Table 10 show that TD synthesis was repressed in cells grown in CS 
broth, was gradually derepressed in cells grown in DS broth, and was sub­
sequently repressed with time in cells grown in CS broth. It is noted 
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that repression of TD formation occurred more rapidly and completely 
within three hours of cellular growth in CS broth than occurred in three 
hours of growth in DS broth containing an excess of isoleucine or leu­
cine. These data indicate that all three amino acids repress the syn­
thesis of the TD more effectively than does isoleucine or leucine alone, 
which supports the concept that multivalent repression is effective in 
regulating TD formation. 
However, ÂÂS synthesis decreased in cells obtained after three and 
four hours of growth in DS broth, and increased slightly in cells trans­
ferred to CS broth. The decrease in AAS formation may aid in explaining 
why the rate of growth of strain 655 is slower in DS broth than it is in 
CS broth (Fig. 2), but it is difficult to explain how the AAS is regu­
lated. It is clear that AAS formation is not greatly affected by the 
presence of any one, or all three, of the amino acids, again indicating 
that multivalent repression is not an effective mechanism for regulating 
the AAS. It is possible that the concentrations of the three amino acids 
employed in CS broth are sufficient to limit synthesis of KV, which 
exerted the most effective Inhibition of AAS activity vitro. The 
decrease in AAS activity observed in extracts of cells grown in DS broth 
may be the result of repression or inhibition of the AAS by KV, which 
would be synthesized during growth in DS broth. Hence, the synthesis or 
activity of the AAS may be primarily regulated by KV. Alternatively, 
AAS synthesis may be regulated by a multivalent repression involving the 
combined effects of Isoleucine, valine, leucine, pantothenate and KV, or 
some combination of these compounds. 
Indirect support for the concept that KV is the primary regulator 
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of the MS is suggested by the observation that KV more effectively 
inhibited MS activity in extracts of cells grown in CS broth then in 
extracts of cells grown in DS broth (Table 7). This observation indi­
cates that the MS is more sensitive to KV in extracts of cells grown 
under conditions in which KV synthesis should be minimal. Therefore, the 
decrease in MS activity in extracts of cells grown under conditions in 
which KV is synthesized may result from the presence of the intermediate. 
However, further experimentation is necessary to determine the effects of 
KV on the growth of strain 655 and on the activity of the MS in extracts 
of cells grown in the presence of KV. 
It was also noted that valine and leucine were less effective as 
inhibitors of TD activity in the extract of cells grown in CS broth than 
in the extract of cells grown in DS broth (Fig. 7 and 8). This observa­
tion suggests that growth in the presence of isoleucine, valine and*leu­
cine decreases the iji vitro sensitivity of the TD to inhibition exerted 
by leucine and valine. This decrease in sensitivity may result from a 
change in conformation of the TD caused by binding of leucine and valine 
(and, perhaps, isoleucine) during growth of the cells under conditions 
that repress the TD. The change in conformation may result in a decreased 
affinity of the TD for binding leucine and valine. 
However, as the TD is repressed under these conditions of growth, the 
concentration of extract employed in these assays was ten-fold greater 
than the concentration employed in assays of TD activity in extracts of 
cells grown under derepressed conditions. Therefore, leucine and valine 
may not be as effective in inhibiting TD activity in assays with increased 
protein concentration but decreased TD activity. 
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Multivalent repression of the enzymes of the ilv pathway is exhibi­
ted in strain LT-2 of typhimurium (Freundlich ^  al«, 1962), and in 
strain W of coll (Umbarger and Freundlich, 1965). The linear arrange­
ment of the structural genes of the ilv pathway has been reported to be 
similar in strain LT-2 of typhimurium and in strain K-12 of coll. 
Employing the names of the enzymes to identify the genes which code for 
the enzymes, the arrangement in these organisms has been established as 
transaminase, dehydrase, TD, RI, MS (Roth and Sanderson, 1966). This 
arrangement does not occur in strain 655 of S^. aureus. Smith and Pattee 
(1967) reported that the linear arrangement in this organism is identi­
cal to the sequence in which the enzymatic reactions occur (Fig. 1). 
Ramakrishnan and Adelberg (1964) demonstrated that multivalent 
repression is effective only in regulating the TD, dehydrase and trans­
aminase in strain K-12 of E^. coli, which, in correlation with the linear 
arrangement of the structural genes, would constitute one operon. They 
suggested that the genes for the AAS and the RI are outside the operon 
in which the other three genes are located, and are regulated by a 
separate operator gene. The results of this study demonstrate that the 
TD and the AAS are not coordinately repressed or derepressed, indicating 
that, in strain 655, the TD and the AAS are regulated by separate opera­
tor genes. Therefore, if the structural genes are arranged as reported 
by Smith and Pattee (1967), and the TD and the AAS are located in sepa­
rate opérons, the remaining structural genes are either located in the 
same operon as the AAS, or there are at least three opérons controlling 
the ilv pathway. However, it is clear that in strain 655, as in strain 
K-12, multivalent repression is not solely responsible for regulating 
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the ilv pathway. 
The results of this study also indicate that the inhibition of 
growth exerted by isoleucine or leucine does not involve the formation 
of false protein, or the repression or inhibition of the MS. Leucine, 
by inhibiting TD activity, may interfere with isoleucine biosynthesis. 
This is supported by the observation that valine reversed the inhibitory 
effects of leucine on the growth of strain 655 and on TD activity. By 
analogy, isoleucine may inhibit growth by interfering with leucine bio­
synthesis, but no data have been obtained in this study to support this 
possibility. It is also possible that the inhibition of growth observed 
in the presence of isoleucine or leucine may involve the remaining 
enzymes of the ilv pathway, or may result from effects which are, as yet, 
unknown. However, further studies are necessary to determine: a) 
whether the remaining enzymes are affected by any or all of the three 
amino acids; b) the number of opérons controlling the ilv pathway; c) 
the effects of KV on the growth of strain 655 and on the AAS; d) whether 
isoleucine affects any of the enzymes of the leucine biosynthetic pathway. 
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SUMMARY 
The growth of strains 655, U9 and 152 of Staphylococcus aureus is 
inhibited by isoleucine and by leucine, and the inhibition is reversed 
by valine. Using cell-free extracts of strain 655, assays were conduc­
ted on four of the five enzymes that are involved in the biosynthesis 
of isoleucine and valine in an attempt to determine whether the inhibi­
tion exerted by isoleucine and leucine involves inhibition of enzyme 
activity or repression of enzyme formation. 
The assays of reductoisomerase activity were not successful because 
non-specific oxidases in the cell-free extracts reacted with the cofactor 
in the presence of several compounds. The assays of dihydroxy acid dehy-
drase activity indicated that the enzyme is specific for the L-isomer of 
DHV and is inhibited by the D-isomer. However, because the quantity of 
L-DHV was very limited, only preliminary studies were possible concerning 
the mechanism by which the dehydrase might be regulated. 
The assays of threonine deaminase (TD) activity demonstrated that 
the TD is stable in 1 M phosphate buffer, has a pH optimum of 8.5 and is 
subject to feedback inhibition by isoleucine and, to a lesser extent, by 
leucine. Valine, which is weakly inhibitory at relatively high concen­
trations, reversed the inhibition exerted by isoleucine and leucine. 
Growth of the cells in the absence and in the presence of isoleucine, 
valine and leucine demonstrated that the TD is maximally repressed in 
cells grown in synthetic media containing all three amino acids, suggest­
ing that synthesis of the TD is controlled by multivalent repression. 
However, the synthesis of the AÂS is not significantly affected by any 
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one of the three amino acids, or by a combination of the three amino 
acids and pantothenate. This observation indicates that the AAS is not 
controlled by multivalent repression, and suggests that the TD and the 
AAS are regulated by separate operator genes. 
The results of this study do not indicate the manner in which isoleu-
cine inhibits the growth of aureus. It has been demonstrated that 
leucine inhibits TD activity, and this inhibition could result in depri­
vation of isoleucine, thereby preventing growth. While it is attractive 
to speculate that isoleucine may act as an analogue of leucine and inhi­
bit an enzyme involved in leucine biosynthesis, no evidence has yet been 
obtained to support this concept. 
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